Document is current
Any future updates will be listed below
-
Authors
Wang, Pingluan https://orcid.org/0000-0002-7817-7709
Ye, Chang https://orcid.org/0000-0003-0236-5671
Zhao, Michelle
Jiang, Bochen https://orcid.org/0000-0001-6686-8847
He, Chuan https://orcid.org/0000-0003-4319-7424
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (HG008935, HG008935, HG008935, HG008935, HG008935)
- License Information
-
More Information
Article History
Received: 3 June 2024
Accepted: 11 March 2025
First Online: 17 April 2025
Competing interests
: C.H. is a scientific founder, a member of the scientific advisory board and equity holder of Aferna Bio and Ellis Bio, a scientific cofounder and equity holder of Accent Therapeutics, and a member of the scientific advisory board of Rona Therapeutics and Element Biosciences. The other authors declare no competing interests.
